182 related articles for article (PubMed ID: 34347291)
1. Active surveillance for intermediate-risk prostate cancer in African American and non-Hispanic White men.
Courtney PT; Deka R; Kotha NV; Cherry DR; Salans MA; Nelson TJ; Kumar A; Luterstein E; Yip AT; Nalawade V; Parsons JK; Kader AK; Stewart TF; Rose BS
Cancer; 2021 Dec; 127(23):4403-4412. PubMed ID: 34347291
[TBL] [Abstract][Full Text] [Related]
2. Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
Deka R; Courtney PT; Parsons JK; Nelson TJ; Nalawade V; Luterstein E; Cherry DR; Simpson DR; Mundt AJ; Murphy JD; D'Amico AV; Kane CJ; Martinez ME; Rose BS
JAMA; 2020 Nov; 324(17):1747-1754. PubMed ID: 33141207
[TBL] [Abstract][Full Text] [Related]
3. Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
Nelson TJ; Javier-DesLoges J; Deka R; Courtney PT; Nalawade V; Mell L; Murphy J; Parsons JK; Rose BS
JAMA Netw Open; 2021 May; 4(5):e219452. PubMed ID: 33999164
[TBL] [Abstract][Full Text] [Related]
4. Metastasis and Mortality in Men With Low- and Intermediate-Risk Prostate Cancer on Active Surveillance.
Courtney PT; Deka R; Kotha NV; Cherry DR; Salans MA; Nelson TJ; Kumar A; Luterstein E; Yip AT; Nalawade V; Parsons JK; Kader AK; Stewart TF; Rose BS
J Natl Compr Canc Netw; 2022 Feb; 20(2):151-159. PubMed ID: 35130495
[TBL] [Abstract][Full Text] [Related]
5. Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018.
Parikh RB; Robinson KW; Chhatre S; Medvedeva E; Cashy JP; Veera S; Bauml JM; Fojo T; Navathe AS; Malkowicz SB; Mamtani R; Jayadevappa R
JAMA Netw Open; 2020 Sep; 3(9):e2018318. PubMed ID: 32986109
[TBL] [Abstract][Full Text] [Related]
6. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
7. Association of Health-Care System With Prostate Cancer-Specific Mortality in African American and Non-Hispanic White Men.
Klebaner D; Courtney PT; Garraway IP; Einck J; Kumar A; Martinez ME; McKay R; Murphy JD; Parada H; Sandhu A; Stewart T; Yamoah K; Rose BS
J Natl Cancer Inst; 2021 Oct; 113(10):1343-1351. PubMed ID: 33892497
[TBL] [Abstract][Full Text] [Related]
8. Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.
Leapman MS; Freedland SJ; Aronson WJ; Kane CJ; Terris MK; Walker K; Amling CL; Carroll PR; Cooperberg MR
J Urol; 2016 Nov; 196(5):1408-1414. PubMed ID: 27352635
[TBL] [Abstract][Full Text] [Related]
9. Racial Disparities in Active Surveillance for Prostate Cancer.
Krishna S; Fan Y; Jarosek S; Adejoro O; Chamie K; Konety B
J Urol; 2017 Feb; 197(2):342-349. PubMed ID: 27596691
[TBL] [Abstract][Full Text] [Related]
10. Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysis.
Preisser F; Nazzani S; Bandini M; Marchioni M; Tian Z; Saad F; Chun FK; Shariat SF; Montorsi F; Huland H; Graefen M; Tilki D; Karakiewicz PI
Int J Urol; 2018 Nov; 25(11):929-936. PubMed ID: 30146729
[TBL] [Abstract][Full Text] [Related]
11. Association Between Prostate-Specific Antigen Screening and Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White US Veterans.
Sherer MV; Qiao EM; Kotha NV; Qian AS; Rose BS
JAMA Oncol; 2022 Oct; 8(10):1471-1476. PubMed ID: 35925581
[TBL] [Abstract][Full Text] [Related]
12. African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study.
Schenk JM; Newcomb LF; Zheng Y; Faino AV; Zhu K; Nyame YA; Brooks JD; Carroll PR; Cooperberg MR; Dash A; Filson CP; Gleave ME; Liss M; Martin FM; Morgan TM; Nelson PS; Thompson IM; Wagner AA; Lin DW
J Urol; 2020 Apr; 203(4):727-733. PubMed ID: 31651227
[TBL] [Abstract][Full Text] [Related]
13. Effect of type of definitive treatment on race-based differences in prostate cancer-specific survival.
Frego N; Labban M; Stone BV; Koelker M; Alkhatib K; Lughezzani G; Buffi NM; Lipsitz SR; Weissman JS; Fletcher SA; Kibel AS; Trinh QD; Cole AP
Prostate; 2023 Aug; 83(11):1099-1111. PubMed ID: 37150867
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment.
Slezak JM; Van Den Eeden SK; Cannavale KL; Chien GW; Jacobsen SJ; Chao CR
Cancer Med; 2020 Nov; 9(22):8530-8539. PubMed ID: 32965775
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration.
McKay RR; Sarkar RR; Kumar A; Einck JP; Garraway IP; Lynch JA; Mundt AJ; Murphy JD; Stewart TF; Yamoah K; Rose BS
Cancer; 2021 Feb; 127(3):403-411. PubMed ID: 33036065
[TBL] [Abstract][Full Text] [Related]
16. Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer.
Butler SS; Mahal BA; Lamba N; Mossanen M; Martin NE; Mouw KW; Nguyen PL; Muralidhar V
Cancer; 2019 Sep; 125(18):3164-3171. PubMed ID: 31150125
[TBL] [Abstract][Full Text] [Related]
17. Long-term depression incidence and associated mortality among African American and White prostate cancer survivors.
Parikh RB; Gallo JJ; Wong YN; Robinson KW; Cashy JP; Narayan V; Jayadevappa R; Chhatre S
Cancer; 2021 Sep; 127(18):3476-3485. PubMed ID: 34061986
[TBL] [Abstract][Full Text] [Related]
18. Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancer.
Mahal BA; Aizer AA; Ziehr DR; Hyatt AS; Choueiri TK; Hu JC; Hoffman KE; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Kim SP; Trinh QD; Nguyen PL
Clin Genitourin Cancer; 2014 Oct; 12(5):e189-95. PubMed ID: 24861952
[TBL] [Abstract][Full Text] [Related]
19. Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer.
Raldow AC; Zhang D; Chen MH; Braccioforte MH; Moran BJ; D'Amico AV
JAMA Oncol; 2015 Jun; 1(3):334-40. PubMed ID: 26181182
[TBL] [Abstract][Full Text] [Related]
20. Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.
Dess RT; Hartman HE; Mahal BA; Soni PD; Jackson WC; Cooperberg MR; Amling CL; Aronson WJ; Kane CJ; Terris MK; Zumsteg ZS; Butler S; Osborne JR; Morgan TM; Mehra R; Salami SS; Kishan AU; Wang C; Schaeffer EM; Roach M; Pisansky TM; Shipley WU; Freedland SJ; Sandler HM; Halabi S; Feng FY; Dignam JJ; Nguyen PL; Schipper MJ; Spratt DE
JAMA Oncol; 2019 Jul; 5(7):975-983. PubMed ID: 31120534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
